Eradicating a common bug in people with stomach cancer can prevent the disease from recurring, research suggests.
Helicobacter pylori, proved to be the cause of most stomach ulcers, has also been linked with stomach cancer.
In a study of 550 people who had stomach cancer surgery, antibiotics which killed the bug cut the risk of a second cancer developing by two-thirds.
There will now be a trial of 56,000 British people to see if killing the bacterium stops the cancer developing.
H. pylori lives in the stomach, and accounts for up to 90% of duodenal ulcers and up to 80% of gastric ulcers.
| Dr Nicholas Talley |
It was famously linked with stomach ulcers by two Australian researchers - one of whom deliberately infected himself to prove the theory - who were awarded the Nobel prize for their discovery in 2005.
The World Health Organisation also classes the bacterium as a leading cause of stomach cancer.
Prevention
Previous trials on eradicating H. pylori as a method of preventing further stomach cancers in patients who have undergone surgery have been conflicting.
But the latest study, done in Japan, found that the strategy could be very useful.
Patients with early stomach cancer underwent a procedure to remove the cancerous cells and surrounding tissue.
Half of them were then treated with a course of drugs designed to eradicate H. pylori - lansoprazole, amoxicillin and clarithromycin - and half received dummy pills and were then examined at six, 12, 24 and 36 months to see if the cancer had reappeared in a different site.
After three years, a second stomach cancer had developed in nine patients in the eradication group compared with 24 in the control group.
For More Information Visit: http://www.prescriptiondrugs1.com
0 Comments:
Post a Comment